Group 1 - The core viewpoint of the article highlights that Suobao Protein (603231.SH) is currently trading at 18.70 yuan, reflecting a decline of 5.22% and is in a state of breaking its initial public offering price [1] - Suobao Protein was listed on the Shanghai Stock Exchange on December 15, 2023, with a total issuance of 47.8648 million shares at an initial price of 21.29 yuan per share, with no existing shares being transferred [1] - The total funds raised from the initial public offering amounted to 1,019.0416 million yuan, with a net amount of 979.4557 million yuan, exceeding the original plan by 424.8731 million yuan [1] Group 2 - The company plans to use the raised funds of 554.5826 million yuan for the construction of a 30,000-ton soybean textured protein production line, a 5,000-ton soybean granular protein production line, a 75T medium-temperature and medium-pressure efficient coal powder boiler project, and to supplement working capital [1] - The total issuance costs for the public offering were 39.5859 million yuan (excluding tax), with underwriting and sponsorship fees amounting to 27.3585 million yuan [1]

Core Viewpoint - The stock of Suobao Protein (603231.SH) is currently trading at 19.17 yuan, reflecting a decline of 1.03% and is in a state of underperformance since its IPO [1] Group 1: IPO Details - Suobao Protein was listed on the Shanghai Stock Exchange on December 15, 2023, with a total issuance of 47.86 million shares, all being new shares without any existing shares being transferred [1] - The IPO price was set at 21.29 yuan per share, and the total funds raised amounted to 1.019 billion yuan, with a net amount of 979.46 million yuan after expenses [1] - The final net fundraising exceeded the original plan by 424.87 million yuan, indicating strong investor interest [1] Group 2: Fund Utilization - The company plans to utilize the raised funds for several projects, including a 30,000-ton soybean textured protein production line, a 5,000-ton soybean granular protein production line, and a 75-ton medium-temperature and medium-pressure efficient coal powder boiler project, as well as for working capital [1] Group 3: Underwriting and Fees - The total issuance costs for the public offering amounted to 39.59 million yuan (excluding tax), with underwriting and sponsorship fees accounting for 27.36 million yuan [1]

Core Viewpoint - The company is expected to achieve significant growth in net profit for 2025, with projections indicating a year-on-year increase of 46.89% to 57.62% for net profit attributable to shareholders, and 56.03% to 66.07% for net profit after deducting non-recurring gains and losses [1] Group 1: Financial Performance - For 2025, the company forecasts a net profit attributable to shareholders of 1.78 to 1.91 billion yuan, and a net profit after deducting non-recurring gains and losses of 1.71 to 1.82 billion yuan [1] - In Q4 2025, the company anticipates a net profit of 0.31 to 0.44 billion yuan, representing a year-on-year growth of 6.1% to 50.2% [1] - The projected revenue for 2025 to 2027 is 17.04 billion yuan, 18.63 billion yuan, and 22.66 billion yuan, with year-on-year growth rates of 9.53%, 9.36%, and 21.63% respectively [2] Group 2: Operational Strategy - The company focuses on high-end manufacturing, energy optimization, and lean management to achieve significant cost reductions and efficiency improvements [1] - The management team actively monitors raw material market trends to capitalize on procurement opportunities, effectively lowering the cost of non-GMO soybean procurement [1] - New high-margin production capacities are expected to come online by the end of 2026, contributing to revenue growth and improving product structure [1] Group 3: Future Projections - The company expects to launch a 30,000-ton soybean textured protein project and a high-end soybean protein production line by December 2026 and June 2027, respectively [1] - The new products, including textured protein and high-end soybean protein, are anticipated to have high profit margins, which will support revenue growth as production capacity is released [1] - The projected net profit for 2025 to 2027 is 1.85 billion yuan, 2.00 billion yuan, and 2.82 billion yuan, with respective year-on-year growth rates of 52.54%, 7.99%, and 41.34% [2]

Group 1 - Shanghai Bunge plans to reduce its stake in Suobao Protein by up to 5,743,615 shares, representing no more than 3% of the total share capital [1] - The reduction will occur through a combination of centralized bidding and block trading, with a maximum of 1,914,500 shares (1% of total share capital) through centralized bidding and 3,829,115 shares (2% of total share capital) through block trading [1] - As of the announcement date, Shanghai Bunge holds 7,179,715 shares, accounting for 3.75% of the total share capital, all of which were acquired before the company's IPO [1] Group 2 - Suobao Protein was listed on the Shanghai Stock Exchange on December 15, 2023, with an issuance of 47,864,800 shares at a price of 21.29 yuan per share, raising a total of 1,019.04 million yuan [2] - The net proceeds from the offering amounted to 979.46 million yuan, exceeding the original plan by 424.87 million yuan [2] - The funds raised will be allocated to the construction of a 30,000-ton soybean textured protein production line, a 5,000-ton soybean granular protein production line, a 75T medium-temperature and medium-pressure efficient coal powder boiler project, and to supplement working capital [2]